Pharmaceuticals, Biotechnology and Life Sciences
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021 Conference call and webcast on Tuesday,…
BRACAnalysis CDx is now the only germline test approved by FDA as a companion diagnostic for treatment of HER2 negative…
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, March 11, 2022 (GLOBE NEWSWIRE) — Roivant Sciences (Nasdaq: ROIV) today…
Daix (France), Long Island City (New York, United States), March 11, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a…
NEW YORK, March 11, 2022 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology…
CAMBRIDGE, Mass., March 11, 2022 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) announced the company will present new Alzheimer’s disease research,…
PHILADELPHIA, March 11, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a…
Monthly information regarding the total number of voting rights and total number of shares of the Company as of February…
CAMBRIDGE, Mass., March 11, 2022 (GLOBE NEWSWIRE) — Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development…
Company announcement – No. 9 / 2022 Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for…